Selv om den kliniske betydning af inducerede antistoffer ikke er fuldt belyst, er udvikling af neutraliserende antistoffer forbundet med reduceret effekt af kliniske og MRI- variabler.
Although the clinical significance of the induction of antibodies has not been fully elucidated, the development of neutralising antibodies is associated with reduced efficacy on clinical and MRI variables.